In 2011 the U.S. Agency for International Development (USAID) funded Strengthening Pharmaceutical Systems (SPS) Program conducted a study on pharmacovigilance systems and performance in sub-Saharan Africa, led by individual focus country National Regulatory Authorities, with support from an interagency agreement between the U.S. Food and Drug Administration (FDA) and USAID.

From April 18-20, 2012 the Pharmacovigilance Meeting, which is being hosted by the Ministry of Health in Kenya, the Pharmacy and Poisons Board, and the Systems for Improved Access to Pharmaceuticals and Services (SIAPS), will bring together partners from the African Regulatory Authorities, WHO, BMGF, EMA, CDC, FDA, USAID, and other key stakeholders to disseminate the study findings and facilitate a dialogue around common needs and opportunities.

The meeting will be held in Nairobi, Kenya and includes a one-day launch of the study publication, Safety of Medicines in Sub-Saharan Africa: Assessment of Pharmacovigilance Systems and their Performance, followed by a two-day intensive workshop where countries will share their current practices and collectively identify operational tools and guidelines needed to implement pharmacovigilance activities with a systems perspective.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s